Cardioxane--ICRF-187 towards anticancer drug specificity through selective toxicity reduction.
Koning
J
J
EuroCetus B.V., Amsterdam, The Netherlands.
Palmer
P
P
Franks
C R
CR
Mulder
D E
DE
Speyer
J L
JL
Green
M D
MD
Hellmann
K
K
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006321:Heart / Q000187:drug effects*; D006801:Humans; D011929:Razoxane / Q000494:pharmacology*
D000970:Antineoplastic Agents; D011929:Razoxane